Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Nivolumab; Drug: Cisplatin; Radiation: Radiation Therapy
Sponsors: University of California, San Francisco; National University Cancer Institute, Singapore; Bristol-Myers Squibb
Not yet recruiting - verified August 2017
http://ift.tt/2x4SPyT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου